Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Down - What's Next?

Veradigm logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped down pre-market, opening at $4.15 versus the prior close of $4.50; MarketBeat reported intraday volatility with the last trade at $4.74 and a volume of 13,773 shares.
  • Analyst and fundamentals: Wall Street Zen raised Veradigm to a "hold" rating, and the company has a market cap of $473.17M, a PE of 23.25, 50-/200-day SMAs near $4.62/$4.71, and offers EHR, revenue cycle management and analytics solutions to healthcare providers.
  • MarketBeat previews top five stocks to own in May.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s share price gapped down before the market opened on Monday . The stock had previously closed at $4.50, but opened at $4.15. Veradigm shares last traded at $4.74, with a volume of 13,773 shares.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Veradigm to a "hold" rating in a research report on Saturday, March 7th.

Check Out Our Latest Report on Veradigm

Veradigm Trading Down 10.2%

The business's 50-day simple moving average is $4.62 and its two-hundred day simple moving average is $4.71. The company has a market capitalization of $473.17 million, a PE ratio of 23.25 and a beta of 0.54.

About Veradigm

(Get Free Report)

Veradigm, Inc NASDAQ: MDRX is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company's offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm's product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines